日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rat somatic genome editing enables ER+ breast cancer modeling.

大鼠体细胞基因组编辑技术可用于构建ER+乳腺癌模型。

Bu Wen, Lee Tobie, Anurag Meenakshi, Ding Yunfeng, Xu Ruixin, He Lillian, Bu Alexandria Z, Nagi Chandandeep, Gutierrez Carolina, Hilsenbeck Susan, Cheng Chonghui, Zhang Bing, Huang Shixia, Xu Jianming, Osborne C Kent, Sreekumar Arun, Chang Eric, Creighton Chad J, Zhang Xiang, Li Yi

Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy Responses.

源自患者的三阴性乳腺癌异种移植模型能够对化疗反应进行解卷积和预测

Lei Jonathan T, Dobrolecki Lacey E, Huang Chen, Srinivasan Ramakrishnan R, Vasaikar Suhas V, Lewis Alaina N, Sallas Christina, Zhao Na, Cao Jin, Landua John D, Moon Chang In, Liao Yuxing, Hilsenbeck Susan G, Osborne C Kent, Rimawi Mothaffar F, Ellis Matthew J, Petrosyan Varduhi, Wen Bo, Li Kai, Saltzman Alexander B, Jain Antrix, Malovannaya Anna, Wulf Gerburg M, Marangoni Elisabetta, Li Shunqiang, Kraushaar Daniel C, Wang Tao, Damodaran Senthil, Zheng Xiaofeng, Meric-Bernstam Funda, Echeverria Gloria V, Anurag Meenakshi, Chen Xi, Welm Bryan E, Welm Alana L, Zhang Bing, Lewis Michael T

Pertuzumab, Trastuzumab, and an Aromatase Inhibitor for HER2-Positive and Hormone Receptor-Positive Metastatic or Locally Advanced Breast Cancer: PERTAIN Final Analysis

帕妥珠单抗、曲妥珠单抗和芳香化酶抑制剂联合治疗HER2阳性及激素受体阳性转移性或局部晚期乳腺癌:PERTAIN最终分析

Arpino, Grazia; de la Haba Rodríguez, Juan; Ferrero, Jean-Marc; De Placido, Sabino; Osborne, C Kent; Klingbiel, Dirk; Revelant, Valentine; Wohlfarth, Christine; Poppe, Raf; Rimawi, Mothaffar F

A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer

一种用于预测 HER2 阳性乳腺癌患者对新辅助拉帕替尼联合曲妥珠单抗治疗(不联合化疗)疗效的多参数分子分类器

Veeraraghavan, Jamunarani; Gutierrez, Carolina; De Angelis, Carmine; Davis, Robert; Wang, Tao; Pascual, Tomas; Selenica, Pier; Sanchez, Katherine; Nitta, Hiroaki; Kapadia, Monesh; Pavlick, Anne C; Galvan, Patricia; Rexer, Brent; Forero-Torres, Andres; Nanda, Rita; Storniolo, Anna M; Krop, Ian E; Goetz, Matthew P; Nangia, Julie R; Wolff, Antonio C; Weigelt, Britta; Reis-Filho, Jorge S; Hilsenbeck, Susan G; Prat, Aleix; Osborne, C Kent; Schiff, Rachel; Rimawi, Mothaffar F

Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach

利用CTD/WGCNA方法鉴定TNBC患者来源异种移植瘤中化疗反应差异的生物标志物

Petrosyan, Varduhi; Dobrolecki, Lacey E; Thistlethwaite, Lillian; Lewis, Alaina N; Sallas, Christina; Srinivasan, Ramakrishnan R; Lei, Jonathan T; Kovacevic, Vladimir; Obradovic, Predrag; Ellis, Matthew J; Osborne, C Kent; Rimawi, Mothaffar F; Pavlick, Anne; Shafaee, Maryam Nemati; Dowst, Heidi; Jain, Antrix; Saltzman, Alexander B; Malovannaya, Anna; Marangoni, Elisabetta; Welm, Alana L; Welm, Bryan E; Li, Shunqiang; Wulf, Gerburg M; Sonzogni, Olmo; Huang, Chen; Vasaikar, Suhas; Hilsenbeck, Susan G; Zhang, Bing; Milosavljevic, Aleksandar; Lewis, Michael T

Biomarkers of Response and Resistance to Palbociclib Plus Letrozole in Patients With ER(+)/HER2(-) Breast Cancer

ER(+)/HER2(-)乳腺癌患者对帕博西尼联合来曲唑治疗的反应和耐药生物标志物

Dowsett, Mitch; Kilburn, Lucy; Rimawi, Mothaffar F; Osborne, C Kent; Pogue-Geile, Katherine; Liu, Yuan; Jacobs, Samuel A; Finnigan, Melanie; Puhalla, Shannon; Dodson, Andrew; Martins, Vera; Cheang, Maggie; Perry, Sophie; Holcombe, Chris; Turner, Nick; Swift, Claire; Bliss, Judith M; Johnston, Stephen

Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study

乳腺癌核心活检样本的Ki67评分系统性高于相应的切除标本:一项多操作者、多中心研究

Acs, Balazs; Leung, Samuel C Y; Kidwell, Kelley M; Arun, Indu; Augulis, Renaldas; Badve, Sunil S; Bai, Yalai; Bane, Anita L; Bartlett, John M S; Bayani, Jane; Bigras, Gilbert; Blank, Annika; Buikema, Henk; Chang, Martin C; Dietz, Robin L; Dodson, Andrew; Fineberg, Susan; Focke, Cornelia M; Gao, Dongxia; Gown, Allen M; Gutierrez, Carolina; Hartman, Johan; Kos, Zuzana; Lænkholm, Anne-Vibeke; Laurinavicius, Arvydas; Levenson, Richard M; Mahboubi-Ardakani, Rustin; Mastropasqua, Mauro G; Nofech-Mozes, Sharon; Osborne, C Kent; Penault-Llorca, Frédérique M; Piper, Tammy; Quintayo, Mary Anne; Rau, Tilman T; Reinhard, Stefan; Robertson, Stephanie; Salgado, Roberto; Sugie, Tomoharu; van der Vegt, Bert; Viale, Giuseppe; Zabaglo, Lila A; Hayes, Daniel F; Dowsett, Mitch; Nielsen, Torsten O; Rimm, David L

Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

IFN信号通路激活与ER阳性乳腺癌中CDK4/6抑制剂耐药性和免疫检查点激活相关

De Angelis, Carmine; Fu, Xiaoyong; Cataldo, Maria Letizia; Nardone, Agostina; Pereira, Resel; Veeraraghavan, Jamunarani; Nanda, Sarmistha; Qin, Lanfang; Sethunath, Vidyalakshmi; Wang, Tao; Hilsenbeck, Susan G; Benelli, Matteo; Migliaccio, Ilenia; Guarducci, Cristina; Malorni, Luca; Litchfield, Lacey M; Liu, Jiangang; Donaldson, Joshua; Selenica, Pier; Brown, David N; Weigelt, Britta; Reis-Filho, Jorge S; Park, Ben H; Hurvitz, Sara A; Slamon, Dennis J; Rimawi, Mothaffar F; Jansen, Valerie M; Jeselsohn, Rinath; Osborne, C Kent; Schiff, Rachel

Towards personalized treatment for early stage HER2-positive breast cancer

迈向早期HER2阳性乳腺癌的个体化治疗

Goutsouliak, Kristina; Veeraraghavan, Jamunarani; Sethunath, Vidyalakshmi; De Angelis, Carmine; Osborne, C Kent; Rimawi, Mothaffar F; Schiff, Rachel

Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer

21基因检测复发评分与淋巴结阳性乳腺癌患者局部区域复发率的相关性

Woodward, Wendy A; Barlow, William E; Jagsi, Reshma; Buchholz, Thomas A; Shak, Steven; Baehner, Frederick; Whelan, Timothy J; Davidson, Nancy E; Ingle, James N; King, Tari A; Ravdin, Peter M; Osborne, C Kent; Tripathy, Debasish; Livingston, Robert B; Gralow, Julie R; Hortobagyi, Gabriel N; Hayes, Daniel F; Albain, Kathy S